Post Title

Adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new Science study in mice.

The results suggest a potential new target for treating obesity-related metabolic disease. scim.ag/4125XB6
https://scim.ag/4125XB6